news_image.jpg

New drug for treatment of Cushing’s Syndrome

07 Oct 2019



New oral drug, levoketoconazole, could be an effective treatment option for Cushing’s syndrome, according to results from a phase III clinical trial reported in The Lancet Diabetes and Endocrinology.

MedPageToday



Issue 46 - Winter 2019 - Endocrine Disruptors

Latest Newsletter

Issue 46 - Winter 2019 - Endocrine Disruptors

Issue 46 - Winter 2019 - Endocrine Disruptors

Newsletter Archive

Previous newsletters can be viewed and downloaded from the archive.

Newsletter Archive